MAP2K5 and breast carcinoma: Amplification or mutation of the MEK5 and ERK5 genes is infrequent; within the data available at catalogue of somatic mutations in cancer (COSMIC, Sanger Institute, UK; www.sanger.ac.uk/genetics/CGP/cosmic), they are relatively uncommon events seen in skin, liver and breast cancer.